WHO vaccine-preventable diseases: monitoring system. 2019 global summary

WHO vaccine-preventable diseases: monitoring system. 2019 global summary

Return to the schedule selection centre form
 
Last updated 31-May-2019 (data as of 29-May-2019)
Next overall update July 2019
2018 data provisionary
EPI mother and child logo  
Immunization schedule for 87 vaccines (Anthrax, , BCG, bOPV, CHOLERA, Dip, Diphteria, DT, DTaP, , DTaPHepB, DTaPHepBIPV, , DTaPHib, DTaPHibHepB, DTaPHibHepBIPV, , DTaPHibIPV, DTaPIPV, DTIPV, , DTwP, , DTwPHepB, DTwPHib, DTwPHibHepB, , , HepA_Adult, HepAHepB, HepA_Pediatric, , HepB_Adult, HepB_Pediatric, HepB_Pediatric, HFRS, HIB, HIB, HibMenC, HPV, Influenza, Influenza_Adult, Influenza_Pediatric, IPV, , JE_Inactd, JE_LiveAtd, , , Measles, MenA, MenAC, MenACW, , MenACWY-135 conj, MenACWY-135 ps, MenB, MenBC, MenC_conj, MM, MMR, MMRV, MR, Mumps, OPV, plague, Pneumo_conj, Pneumo_ps, Rabies, Rotavirus, Rubella, TBE, Td, Tdap, Tdap, TdaPIPV, TdIPV, Tetanus, TT, Tularemia, Typhoid, TyphoidHepA, Varicella, , VitaminA, YF, Zoster)
For 1 country (SRB) and for no specific region.
16 rows
Country Antigens Description Schedules Entire country Comments

Europe

Serbia BCG Bacille Calmette-Guérin vaccine birth; Yes
  DT Tetanus and diphtheria toxoid childrens' dose 7 years; Yes
  DTaPHibIPV Diphtheria and tetanus toxoid with acellular pertussis, Hib and IPV vaccine 8, 14, 20 weeks; 18 months; Yes
  HepB_Adult Hepatitis B adult dose vaccine Yes pre-exposure and postexposure profilaxis of Hepatitis B, special risk groups, healthcare workers
  HepB_Pediatric Hepatitis B pediatric dose vaccine birth; 4 weeks; 5 months; Yes
  HIB Haemophilus influenzae type b vaccine Yes special risk groups, some chronic disease patients
  Influenza_Adult Influenza adult dose vaccine >65 years; Yes and adults with chronic conditions, pregnant women, healthcare workers, residents living in long-term care facilities, other risk groups
  Influenza_Pediatric Influenza pediatric dose vaccine >6 months; Yes and children with chronic conditions
  MenACWY-135 conj Meningococcal ACWY-135 conjugate vaccine Yes some risk groups, chronic disease patients, travellers
  MMR Measles mumps and rubella vaccine 12 months; 7 years; Yes and healthcare workers
  OPV Oral polio vaccine 7, 14 years; Yes
  Pneumo_conj Pneumococcal conjugate vaccine 8, 14, 20 weeks; 18 months; Yes special risk groups, chronic disease patients
  Pneumo_ps Pneumococcal polysaccharide vaccine Yes some chronic diseases patients
  Td Tetanus and diphtheria toxoid for older children / adults vaccube 14 years; Yes
  TT Tetanus toxoid vaccine Yes injured persons; number of doses depends on previous vaccination status/date of previous administration of the last dose of tetanus toxoid containing vaccine
  YF Yellow fever vaccine Yes travellers


Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.